Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor cells serve as critical targets for photodynamic therapy through selective photosensitization. The process leverages unique features of tumors—such as altered vasculature and metabolic activity—to achieve preferential localization and activation of therapeutic agents with minimal impact on healthy tissues. This approach enables effective destruction not only through direct cytotoxicity but also via disruption of blood supply and stimulation of anti-tumor immunity.
Photosensitizer activation by light leads to ROS generation, causing direct cytotoxicity, vascular damage, and immune stimulation.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Cell (Photosensitization).